These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
448 related articles for article (PubMed ID: 30576763)
1. Augmentation agents to serotonin reuptake inhibitors for treatment-resistant obsessive-compulsive disorder: A network meta-analysis. Zhou DD; Zhou XX; Li Y; Zhang KF; Lv Z; Chen XR; Wan LY; Wang W; Wang GM; Li DQ; Ai M; Kuang L Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 90():277-287. PubMed ID: 30576763 [TBL] [Abstract][Full Text] [Related]
2. Comparative efficacy and tolerability of antipsychotics as augmentations in adults with treatment-resistant obsessive-compulsive disorder: A network meta-analysis. Zhou DD; Zhou XX; Lv Z; Chen XR; Wang W; Wang GM; Liu C; Li DQ; Kuang L J Psychiatr Res; 2019 Apr; 111():51-58. PubMed ID: 30677645 [TBL] [Abstract][Full Text] [Related]
3. Pharmacological augmentation of serotonin reuptake inhibitors in patients with obsessive-compulsive disorder: A network meta-analysis. Maiti R; Mishra A; Srinivasan A; Mishra BR Acta Psychiatr Scand; 2023 Jul; 148(1):19-31. PubMed ID: 37177823 [TBL] [Abstract][Full Text] [Related]
4. Antipsychotic Augmentation of Serotonin Reuptake Inhibitors in Treatment-Resistant Obsessive-Compulsive Disorder: An Update Meta-Analysis of Double-Blind, Randomized, Placebo-Controlled Trials. Dold M; Aigner M; Lanzenberger R; Kasper S Int J Neuropsychopharmacol; 2015 May; 18(9):. PubMed ID: 25939614 [TBL] [Abstract][Full Text] [Related]
5. Clinical Recommendations for Augmentation Agents in Obsessive-Compulsive Disorder Partially Responsive to Serotonin Reuptake Inhibitors. Gautam M J Clin Psychopharmacol; 2023 Jul-Aug 01; 43(4):369-377. PubMed ID: 37335203 [TBL] [Abstract][Full Text] [Related]
6. Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomized, placebo-controlled trials. Dold M; Aigner M; Lanzenberger R; Kasper S Int J Neuropsychopharmacol; 2013 Apr; 16(3):557-74. PubMed ID: 22932229 [TBL] [Abstract][Full Text] [Related]